Skip to main content
Inify Laboratories AB logo

Inify Laboratories AB — Investor Relations & Filings

Ticker · INIFY ISIN · SE0017486103 LEI · 549300306YYJ3BX3VB98 ST Human health and social work activities
Filings indexed 339 across all filing types
Latest filing 2024-11-29 Report Publication Anno…
Country SE Sweden
Listing ST INIFY

About Inify Laboratories AB

https://www.inify.com/

Inify Laboratories provides cancer diagnostics through ultramodern laboratory services within pathology. The company utilizes a fully digital, standardized, and AI-supported workflow for histopathology analysis. This integrated service model is designed to optimize the entire diagnostic process, from sample receipt to final report, ensuring high quality and significantly reduced turnaround times for clinical partners. Initially focused on prostate cancer, the company has expanded its diagnostic capabilities to include other areas such as gastroenterology. By streamlining the clinical pathway, Inify Laboratories enables healthcare providers to receive faster results, which facilitates earlier patient follow-up and treatment planning.

Recent filings

Filing Released Lang Actions
Financial calendar
Report Publication Announcement Classification · 99% confidence The document is titled 'Financial calendar' and lists future dates for various corporate events, specifically mentioning 'Quarterly Report', 'Half-yearly Report', 'Annual Report', and 'Annual General Meeting'. It does not contain the content of any of these reports, but rather announces *when* they will be published. This fits the definition of announcing the publication of reports. Since there is no specific code for a 'Financial Calendar', and it is an announcement about future report publication dates, the most appropriate classification is Report Publication Announcement (RPA), as it signals upcoming releases.
2024-11-29 English
Inify Laboratories - notice of Extraordinary General Meeting on December 6, 2024
Report Publication Announcement Classification · 95% confidence The document is a short announcement (1633 characters) inviting shareholders to an Extraordinary General Meeting (EGM) and providing instructions on how to access the full meeting materials. It explicitly states 'Please find attached the invitation' and directs readers to the company website. According to the 'Menu vs Meal' rule, this is an announcement of a meeting/report rather than the full proxy statement or meeting materials themselves, making it a Report Publication Announcement (RPA).
2024-11-15 English
Inify Laboratories: Notice of Extraordinary General Meeting and proposed fully guaranteed equity issue with proceeds of SEK 150 million
Share Issue/Capital Change Classification · 95% confidence The document is a formal announcement regarding a proposed fully guaranteed equity issue (private placement and repair issue) by Inify Laboratories. It details the purpose of the capital raise (SEK 150 million for UK expansion), the involvement of guarantors, and the upcoming Extraordinary General Meeting (EGM) to authorize the issuance. This falls under the category of capital and financing updates, as it describes the company's fundraising activities and capital structure changes.
2024-11-15 English
Inify Laboratories – kallelse till extra bolagsstämma 6 december 2024
AGM Information Classification · 95% confidence The document is a formal notice ('kallelse') for an Extraordinary General Meeting ('extra bolagsstämma') scheduled for December 6, 2024. It provides the date, purpose, and instructions for shareholders. According to the 'Menu vs Meal' rule, this is a notification document regarding a meeting rather than the meeting materials themselves or the voting results. Since it serves as a formal regulatory notice for a shareholder meeting, it falls under the Proxy Solicitation & Information Statement category as it initiates the proxy process for the upcoming meeting.
2024-11-15 Swedish
Inify Laboratories: Notice of Extraordinary General Meeting and proposed fully guaranteed equity issue with proceeds of SEK 150 million
Capital/Financing Update Classification · 98% confidence The document is titled "Inify Laboratories: Notice of Extraordinary General Meeting and proposed fully guaranteed equity issue with proceeds of SEK 150 million". It explicitly mentions calling for an Extraordinary General Meeting (EGM) to resolve on the authorization for the board to issue new shares (a Private Placement and a Repair Issue). This content directly relates to corporate financing activities, capital structure changes, and shareholder meetings required to approve such actions. While it mentions an EGM (which might suggest AGM-R or PSI), the primary focus and substance revolve around the proposed equity issue and financing details (SEK 150 million). This strongly aligns with the definition of Capital/Financing Update (CAP). It is not a full Annual Report (10-K), an Earnings Release (ER), or a standard Dividend Notice (DIV). Since it announces a specific financing event requiring shareholder approval, CAP is the most precise fit, although it also contains elements of a notice for a meeting.
2024-11-15 English
Inify Laboratories - kallelse till extra bolagsstämma 6 december 2024
AGM Information Classification · 99% confidence The document is titled "Kallelse till extra bolagsstämma i Inify Laboratories AB (publ)" which translates to 'Notice of Extraordinary General Meeting in Inify Laboratories AB (publ)'. It details the date, time, location, registration requirements, and the proposed agenda for an Extraordinary General Meeting (EGM). The agenda includes a proposal for a resolution regarding authorizing the board to issue new shares (emissionsbemyndigande). This content is characteristic of materials sent to shareholders to inform them about and solicit their votes for a general meeting. This aligns perfectly with the definition of Proxy Solicitation & Information Statement (PSI), which covers materials for general meetings. While it is a notice for a meeting, the comprehensive nature, including the proposed resolution and the proxy form attachment, makes PSI a better fit than just a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS).
2024-11-15 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.